Percentage of patients who experienced individual non-severe ocular manifestations of herpes zoster (⩾5% in either group)
| Non-severe ocular manifestations | Treatment group | ||
|---|---|---|---|
| Famciclovir 500 mg three times daily | Aciclovir 800 mg 5 × daily | ||
| Punctate epithelial keratopathy | 26% | 21% | |
| Inflammation of the conjunctiva | 20% | 24% | |
| Anterior subepithelial infiltrates | 18% | 18% | |
| Dendriform keratopathy | 9% | 10% | |
| Epithelial defect | 8% | 9% | |
| Episcleritis | 8% | 10% | |
↵Each percentage is based on the number of patients in the treatment group minus those patients who had the manifestation in question at baseline and those patients who had no data for the manifestation post-first dose of study medication.